{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:48:33Z","timestamp":1772016513993,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Exxon Mobil-NUS Research"},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"NMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"NMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jcmgh.2020.12.009","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T02:36:47Z","timestamp":1608172607000},"page":"1313-1325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Predicting HCC Response to Multikinase Inhibitors With In\u00a0Vivo Cirrhotic Mouse Model for Personalized Therapy"],"prefix":"10.1016","volume":"11","author":[{"given":"Daniel Q.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halisah","family":"Jumat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Xin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng Gee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Kow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iyer","family":"Shridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Ting","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin Huei","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwyneth","family":"Soon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierce","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yock Young","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2020.12.009_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A\u00a0global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jhep.2016.09.013","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection","volume":"66","author":"Chayanupatkul","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib4","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Hoshida","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","article-title":"Cytokine receptors and signaling in hepatic stellate cells","volume":"21","author":"Pinzani","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib6","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.3390\/ijms15069422","article-title":"Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development","volume":"15","author":"Tu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.21564","article-title":"Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?","volume":"45","author":"Lee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib8","first-page":"1216","article-title":"Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance","volume":"26","author":"Tanigawa","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/hep.30366","article-title":"Vessels That encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma","volume":"70","author":"Fang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jhep.2017.06.026","article-title":"Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase III studies","volume":"67","author":"Bruix","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib13","doi-asserted-by":"crossref","first-page":"20160","DOI":"10.18632\/oncotarget.3969","article-title":"Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development","volume":"6","author":"Gu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ijc.32564","article-title":"Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification","volume":"146","author":"Hu","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2016.5059","article-title":"Effect of background liver cirrhosis on outcomes of hepatectomy for hepatocellular carcinoma","volume":"152","author":"Sasaki","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/MCG.0b013e31818ddfc6","article-title":"Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis","volume":"43","author":"W\u00f6rns","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2020.04.009","article-title":"Establishment and preclinical therapy of patient-derived hepatocellular carcinoma xenograft model","volume":"223","author":"Wu","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51189-7","article-title":"A\u00a0murine model demonstrating reversal of structural and functional correlates of cirrhosis with progenitor cell transplantation","volume":"9","author":"Muthiah","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib19","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"IMbrave150 Investigators. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.21037\/hbsn.2016.01.01","article-title":"In\u00a0vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents","volume":"5","author":"Shrum","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib21","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.3748\/wjg.v24.i36.4152","article-title":"Ten years of sorafenib in hepatocellular carcinoma: are there any predictive and\/or prognostic markers?","volume":"24","author":"Marisi","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/ijms18020405","article-title":"Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy","volume":"18","author":"Tahmasebi Birgani","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib23","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.2174\/13816128113199990590","article-title":"VEGF signaling in cancer treatment","volume":"20","author":"Sia","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib24","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.addr.2014.09.009","article-title":"Lessons from patient-derived xenografts for better in\u00a0vitro modeling of human cancer","volume":"79\u201380","author":"Choi","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nprot.2015.080","article-title":"An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis","volume":"10","author":"Reiberger","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib28","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.12659\/MSM.894617","article-title":"Prognostic value of VEGF in hepatocellular carcinoma patients treated with sorafenib: a meta-analysis","volume":"21","author":"Cao","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s12885-018-4459-6","article-title":"PDXliver: a database of liver cancer patient derived xenograft mouse models","volume":"18","author":"He","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib30","first-page":"289","article-title":"Establishment of NOD\/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissue","volume":"25","author":"Yan","year":"2013","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archsurg.136.1.25","article-title":"Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation","volume":"136","author":"Tamura","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib32","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijsu.2013.10.001","article-title":"Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: a case-controlled study","volume":"11","author":"Yip","year":"2013","journal-title":"Int J Surg"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib33","series-title":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.jcmgh.2020.12.009_bib34","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2011-300593","article-title":"Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver","volume":"62","author":"Zuo","year":"2013","journal-title":"Gut"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X20302083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X20302083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:28:33Z","timestamp":1762453713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X20302083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"alternative-id":["S2352345X20302083"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2020.12.009","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting HCC Response to Multikinase Inhibitors With In\u00a0Vivo Cirrhotic Mouse Model for Personalized Therapy","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}